期刊文献+

环孢素A、维拉帕米、川芎嗪对胃癌多药耐药细胞株SGC-7901/ADR逆转作用的研究 被引量:2

The Study of the Reversal Effect of Cyclosporin A,Verapamil,and Tetramethylpyrazine Against the Multiple Drug Resistance Gastric Cancer Cell Line SGC-7901/ADR
暂未订购
导出
摘要 目的:探讨环孢素A(CsA)、维拉帕米(VP)、川芎嗪(TMP)对胃癌多药耐药细胞株SGC-7901/ADR耐药性的逆转作用。方法:采用四甲基偶氮唑盐(MTT)比色法观察SGC-7901/ADR对化疗药氟尿嘧啶(5-FU)的耐药性,选择CsA、VP、TMP的非细胞毒性剂量,并观察其与5-Fu联合对SGC-7901/ADR的逆转作用。结果:SGC-7901/ADR对化疗药5-FU具有耐药性,相对耐药性(RF)为97.49;CsA 3.0mg/L、VP 10.0mg/L、TMP 300.0mg/L以下为SGC-7901/ADR细胞的非细胞毒性剂量,除CsA外,VP和TMP对SGC-7901/ADR的逆转作用呈剂量依赖关系;300.0mg/LTMP较10.0mg/L VP逆转作用强(P<0.01),使SGC-7901/ADR相对耐药性降至12.89,将5-FU IC50由13.001mg/L下调到1.542mg/L,逆转倍数是8.43倍。结论:SGC-7901/ADR对5-FU具有耐药性,300.0mg/L TMP是SGC-7901/ADR细胞多药耐药性最有效的逆转剂。 Objective: To investigate the reversal effect of Cyclosporin A (CsA) , Verapamil ( VP ), and Tetramethylpyrazine (TMP) against the multi drug resistance (MDR) gastric cancer cell line SGC -7901/ADR. Methods: MTr assay was used to assess the sensitivity of SGC -7901/ADR cells to Fluorouracil (5-FU). CsA, VP, and TMP at non-toxic doses were separately applied together with 5 - FU to examine potential reversal effect against SGC - 7901/ADR cells by each agent. Resuits: SGC-7901/ADR cells are resistant to 5-FU with relative resistance (RF) of 97.49. The non-cytotoxic dose limits for CsA, VP, and TMP are 3.0 mg/L, 10.0 mg/L, and 300.0 mg/L respectively. Both VP and TMP but not CsA exert dose - dependent reversal effect against SGC -7901/ADR cells with TMP at 300.0 mg/L exerting stronger reversal effect comparing with VP at 10.0mg/L ( P〈 0.01 ). At 300.0 mg/L, TMP reduces the RF of SGC - 7901/ADR cells to the value of 12.89 and lowers the IC50 of 5 -FU from 13. 001 mg/L to 1. 542 mg/L with a reversal fold of 8.43. Conclusion: Multi drug resistance cell line SGC - 7901/ADR is resistant to 5 - FU while TMP at 300.0 mg/1 is the most effective reversal agent examined here against SGC - 7901/ADR cells.
出处 《包头医学院学报》 CAS 2008年第3期230-232,共3页 Journal of Baotou Medical College
关键词 胃癌 多药耐药 SGC-7901/ADR细胞 逆转 Gastric Cancer Multi drug resistance (MDR) SGC-7901/ADR cell Reversal
  • 相关文献

参考文献12

  • 1Lopes EC, Scolnik M, Alvarez E, et al. Modulator activity of psc833 and cycloporin -A in cincristine and doxoubic in selected multidrug resistant murine leukemic cells [ J ]. Leu K Res ,2001,25( 1 ) :85 -93.
  • 2Shiraki N, Okamura K, Tokunaga J, et al. Bromocriptine reverses P - glycoprotein - mediated multidrug resistance in tumor or cells [ J ]. Jpn J Cancer Res, 2002,93 : 209 - 215.
  • 3Britton RA, Green JA, Warenius HM. Cellular glutathione (GSH) and glutathione S -transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents[J]. Int J Radiat Oncol Biol Phys,1992,24(3): 527 -531.
  • 4杨琳,朱兆华.维拉帕米对多药耐药胃癌细胞耐药逆转作用的研究[J].中华消化杂志,2002,22(2):112-113. 被引量:10
  • 5Vassetzky TS, Alghisi GC, Gasser SM, et al. DNA topoisomerase Ⅱ mutation and resistance to anti - tumor drugs [ J ]. Sioessays, 1995,17 (9) :767 - 774.
  • 6Choi JII, Lim IIY, Joo ILJ, et al. Expression of multidrug resistance - associated protein Ⅰ , P - glyeoprotein, and thymidylate synthase in gastric cancer patients treated with 5 - fluorouracil and doxorubicin -based adjuvant chemotherapy after curative resection [ J ]. Br J Cancer, 2002,86 ( 10 ) : 1578 - 1585.
  • 7赵燕秋,肖冰,樊代明.Bax基因对人胃癌耐药细胞多药耐药性的逆转作用[J].中华消化杂志,2000,20(1):8-10. 被引量:15
  • 8Scheithauer W, Schenk T, Czejka M. Pharmacodinetic interation between pirubicin and the multidrug resistance recerting agent D - veraamil [ J ]. Br J Cancer, 1993,68 ( 1 ) : 8 - 9.
  • 9王玉良 巴彦坤.川芎嗪对心血管组织的药理和电生理作用—一种新的钙离子拮抗剂[J].中西医结合杂志,1985,5(5):291-291.
  • 10梁蓉,杨平地,陈协群,白庆咸,黄高升.川芎嗪对白血病HL-60/VCR细胞多药耐药的逆转及其机制研究[J].中华血液学杂志,1999,20(6):323-324. 被引量:50

二级参考文献8

  • 1胡艳平,刘健,王庆端,叶启霞,张覃沐.川芎嗪和维拉帕米纠正阿霉素对小鼠艾氏腹水癌的抗药性[J].药学学报,1993,28(1):75-78. 被引量:42
  • 2郭和清,解放军医学杂志,1996年,21卷,263页
  • 3郭和清,临床泌尿外科杂志,1996年,11卷,65页
  • 4Yang E,Blood,1996年,88卷,386页
  • 5Yang J M,Cancer Res,1994年,54卷,730页
  • 6胡艳平,药学学报,1993年,28卷,75页
  • 7Chen C J,Cell,1986年,47卷,381页
  • 8蔡学君,中国肿瘤临床,1992年,21卷,增刊,67页

共引文献98

同被引文献16

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部